- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Whole blood, serum, plasma single drug assay kit, 5 ng/mL |
| Catalog No. | CD-00136 |
| Description | The whole blood, serum, plasma single drug assay kit is a specialized bioanalytical tool designed to detect specific drug components at concentrations as low as 5 ng/mL in biological samples. Suitable for use in whole blood, serum and plasma samples, the kit is easy to use and highly sensitive, ensuring accurate drug quantification in complex biological matrices. |
| Sample Type | Urine |
| Application | The product can be used to detect and quantitatively measure the concentration of a single drug in whole blood, serum and plasma samples. |
| Operating Temperature | Store at 4-30°C. |
| Transportation Condition | Transportation at room temperature. |
| Cut Off | 5 ng/mL |
In the fields of pharmaceutical research, clinical pharmacology, and toxicology studies, accurate quantification of drug concentrations in biological matrices is critical for understanding drug metabolism, evaluating therapeutic efficacy, and ensuring medication safety. Traditional drug detection methods, such as high-performance liquid chromatography (HPLC) or gas chromatography-mass spectrometry (GC-MS), often require complex sample pretreatment, expensive equipment, and professional operational skills, which limit their application in high-throughput screening or on-site research scenarios.
Against this backdrop, the demand for rapid, sensitive, and user-friendly bioanalytical tools has grown significantly. Biological samples like whole blood, serum, and plasma are the most commonly used matrices for drug concentration detection, as they directly reflect the drug’s distribution and dynamic changes in the human body. However, these matrices contain a large number of interfering substances (such as proteins, lipids, and endogenous metabolites), which pose great challenges to the specificity and accuracy of drug detection.
In pharmaceutical R&D, researchers need to monitor drug concentrations in animal models or early clinical trials to optimize dosage regimens and avoid adverse reactions caused by excessive drug levels. A low detection limit is essential here, as many drugs exhibit therapeutic effects at nanogram-level concentrations.
In forensic toxicology, rapid identification of drug residues in biological samples is crucial for investigating cases related to drug abuse or drug-facilitated crimes. The assay kit needs to be compatible with multiple sample types to adapt to different on-site sampling conditions.
In academic research on drug metabolism, studying the pharmacokinetic profiles of new drugs requires repeated, large-scale detection of drug concentrations in serum or plasma samples. Simplified operation procedures and stable detection performance can greatly improve research efficiency.
This whole blood, serum, plasma single drug assay kit (Cat.No: CD-00136) is developed to address these industry pain points. With a detection limit as low as 5 ng/mL, it meets the sensitivity requirements of most preclinical and clinical research scenarios. Meanwhile, its compatibility with three common biological matrices eliminates the need for researchers to switch between different detection kits for different samples, reducing experimental complexity and cost.
Broad Sample Compatibility: Designed to work with whole blood, serum, and plasma samples without the need for additional sample modification or matrix-specific adaptation. This feature allows researchers to use the same kit for different sample types, saving time and avoiding errors caused by kit replacement.
Ultra-Low Detection Limit: Achieves a cut-off value of 5 ng/mL, which is comparable to many advanced laboratory detection methods. It can accurately quantify trace drug components in biological matrices, meeting the requirements of pharmacokinetic studies and low-dose drug research.
Simplified Operation Process: Does not require complex sample pretreatment steps (such as protein precipitation or liquid-liquid extraction) that are common in traditional methods. Researchers only need to follow basic sample addition and incubation procedures, reducing the reliance on professional technical personnel.
Stable Storage and Transportation: Can be stored at 4-30°C and transported at room temperature. This eliminates the need for cold chain logistics, reducing transportation costs and the risk of kit performance degradation due to temperature fluctuations during transit.
High Specificity for Target Drugs: Adopts a specific recognition mechanism (consistent with industry-standard immunoassay principles) to avoid interference from endogenous substances in whole blood, serum, or plasma. It ensures that the detection results only reflect the concentration of the target drug, reducing false positive or false negative rates.
Improves Research Efficiency: Compared with traditional HPLC/GC-MS methods that take hours to complete a single sample detection, this kit shortens the detection cycle (consistent with the average time of similar immunoassay kits in the market). It supports high-throughput detection, allowing researchers to process multiple samples simultaneously and accelerate the progress of experiments.
Reduces Experimental Costs: Eliminates the need for expensive analytical instruments (such as mass spectrometers) and reduces the consumption of reagents for sample pretreatment. For small and medium-sized laboratories or research teams with limited budgets, it provides a cost-effective alternative to high-end detection equipment.
Enhances Result Reliability: Built with quality control components (in line with industry practices for assay kits) to ensure the consistency and repeatability of detection results. Each batch of kits undergoes strict performance verification, reducing the variability of experimental data caused by kit quality issues.
Widely Applicable to Research Scenarios: Suitable for pharmaceutical R&D, preclinical toxicology testing, clinical pharmacology studies, and forensic toxicology research. Its versatility allows it to meet the diverse needs of different research fields, expanding the scope of potential users.
Low Technical Threshold: The operation process is designed to be user-friendly, with detailed instructions that guide researchers through each step. Even personnel with limited experience in bioanalytical techniques can complete the detection accurately, reducing the training cost for laboratory teams.
For research use only, not for clinical use.
|
There is no product in your cart. |
Copyright © 2025 Alta DiagenoTech. All rights reserved.
